Latest Medulloblastoma Stories
-- TRXE-009 distinguished by ability to kill chemo-resistant adult and paediatric brain cancer cells SYDNEY, April 17, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen, today
-- Potent killing of highly resistant adult and pediatric brain cancer cells SYDNEY, March 4, 2015 /PRNewswire/ -- Australian/US biotechnology company, Novogen Limited (ASX:NRT; NASDAQ:NVGN),
HOUSTON, June 27, 2014 /PRNewswire/ -- The Burzynski Research Institute, Inc.
Whitehead Institute scientists have identified a genetic cause of a facial disorder known as hemifacial microsomia (HFM).
Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, applauds Seattle Seahawks Mascot Blitz the Hawk for delivering high-fives and hugs to pediatric brain
Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses a new experimental approach to treating specific brain cancer developed by researchers at
Proton therapy, an external beam radiotherapy in which protons deliver precise radiation doses to a tumor and spare healthy organs and tissues, is cost-effective in treating medulloblastomas, fast-growing brain tumors that mainly affect children, when compared to standard photon radiation therapy.
- a slit in a tire to drain away surface water and improve traction.